Bill of Health

NOVEMBER 15, 2023

DEA has done little to reduce the appearance of agency capture by the Opioid Treatment Program (OTP) industry, while FDA was years behind the evidence in approving over-the-counter naloxone. Code § 1701 et seq.

Governance 174

Governance Public Health Telemedicine COVID-19 174

Healthcare Law Today

NOVEMBER 9, 2022

Starting January 1, 2023, Medicare will cover telehealth-based treatment services delivered by federally-accredited opioid treatment programs (OTPs), commonly referred to as “methadone clinics.” This flexibility will be in place until the end of CY 2023.

Medicare 52

Medicare Medicare COVID-19 Telemedicine 52

Health Law Advisor

MARCH 7, 2023

Both the proposed rules related to telemedicine prescribing of Schedule III-V non-narcotic controlled substances, and the separate proposed rules related to telemedicine prescribing of buprenorphine, were published in the Federal Register on March 1, 2023. Are the proposed record-keeping obligations reasonable and/or sufficient? 1301.28.

Telemedicine 52

Telemedicine COVID-19 FDA Compliance 52

HIPAA Journal

DECEMBER 22, 2022

trillion omnibus appropriations bill has been released by the House and Senate Appropriations Committees which, if passed, will ensure that the government remains funded until September 30, 2023. The text of a $1.7 The Senate has already started debating the bill and the House is due to consider the bill this week.

FDA 115

FDA COVID-19 Governance Medicaid 115

C&M Health Law

JANUARY 25, 2023

On December 29, President Joe Biden signed into law the Consolidated Appropriations Act, 2023 ( P.L. We expect issues regarding regulation of diagnostic tests and mental health parity enforcement to resurface in the new Congress. 117-164 ) (the “Act”)—an approximately $1.7 It is unclear whether the PHE will be extended beyond April.

Medicaid 104

Medicaid Medicaid Medicare Medicare 104